Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co.
625 F.3d 719, 96 U.S.P.Q. 2d (BNA) 1830, 2010 U.S. App. LEXIS 22659, 2010 WL 4286305
Court of Appeals for the Federal Circuit·Decided November 1, 2010·No. 2010-1105·Published·Cited by 6 cases
Opinions
NEWMAN, Circuit Judge, with whom RADER, Chief Judge, and LOURIE and LINN, Circuit Judges, join, dissents from the denial of the petition for rehearing en banc.
Prior report: 611 F.3d 1381.
Free access — add to your briefcase to read the full text and ask questions with AI
Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co., 625 F.3d 719, 96 U.S.P.Q. 2d (BNA) 1830, 2010 U.S. App. LEXIS 22659, 2010 WL 4286305 (Fed. Cir. 2010).
625 F.3d 719 (Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
Onyx Therapeutics, Inc. v. CIPLA Limited
D. Delaware, 2020
Purdue Pharma, L.P. v. Collegium Pharmaceutical, Inc. <b><font color="red"> LEAD CASE</font></b>
D. Massachusetts, 2018
Purdue Pharma L.P. v. Collegium Pharm., Inc.
335 F. Supp. 3d 149 (District of Columbia, 2018)
Bayer Pharma AG v. Watson Laboratories, Inc.
212 F. Supp. 3d 489 (D. Delaware, 2016)
Eli Lilly and Co. v. Sicor Pharmaceuticals, Inc.
426 F. App'x 892 (Federal Circuit, 2011)
Sun Pharmaceutical Industries, Ltd. v. Eli Lilly & Co.
625 F.3d 719 (Federal Circuit, 2010)